Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY | 17-AAG |
FIMM | Tanespimycin |
CTRPv2 | tanespimycin |
PharmacoGx | 17-AAG |
Database | Identifier |
---|---|
Smiles: | CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC |
Inchikey: | AYUNIORJHRXIBJ-TXHRRWQRSA-N |
Pubchem: | 6505803 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | S100A16 | GDSC1000 | pan-cancer | AAC | 0.25 | 9e-09 |
mRNA | GBE1 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-09 |
mRNA | SALL2 | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-09 |
mRNA | UBA52 | GDSC1000 | pan-cancer | AAC | -0.2 | 9e-09 |
mRNA | CD44 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-09 |
mRNA | HSF2 | GDSC1000 | pan-cancer | AAC | -0.2 | 9e-09 |
mRNA | SMARCA4 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-08 |
mRNA | AIFM2 | CCLE | pan-cancer | AAC | 0.28 | 1e-08 |
mRNA | ISL1 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-08 |
mRNA | FNDC3B | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |